Heartflow (NASDAQ:HTFL) Upgraded by Zacks Research to Hold Rating

Zacks Research upgraded shares of Heartflow (NASDAQ:HTFL) to a hold rating in a research report released on Wednesday,Zacks.com reports.

Several other research firms have also weighed in on HTFL. Piper Sandler started coverage on shares of Heartflow in a research report on Tuesday. They set an “overweight” rating and a $38.00 price objective for the company. JPMorgan Chase & Co. assumed coverage on Heartflow in a research note on Tuesday. They set an “overweight” rating and a $36.00 price target for the company. Wall Street Zen upgraded shares of Heartflow to a “hold” rating in a report on Saturday, August 16th. Morgan Stanley started coverage on shares of Heartflow in a research report on Tuesday. They set an “equal weight” rating and a $35.00 target price on the stock. Finally, Canaccord Genuity Group assumed coverage on Heartflow in a research report on Tuesday. They set a “buy” rating and a $35.00 price objective on the stock. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Heartflow has a consensus rating of “Moderate Buy” and a consensus target price of $35.80.

Heartflow Price Performance

Heartflow stock opened at $31.07 on Wednesday. Heartflow has a 52-week low of $26.56 and a 52-week high of $36.68.

About Heartflow

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.